Feasible concomitant treatment with eltrombopag and oral anticoagulation in a patient with chronic immune thrombocytopenia and severe cardiac comorbidities

Platelets. 2014;25(4):309-10. doi: 10.3109/09537104.2013.770137. Epub 2013 Feb 27.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Heart Diseases / complications*
  • Humans
  • Male
  • Purpura, Thrombocytopenic, Idiopathic / complications*
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Receptors, Fc / therapeutic use*
  • Recombinant Fusion Proteins / therapeutic use*
  • Thrombocytopenia / drug therapy*
  • Thrombocytopenia / immunology*
  • Thrombopoietin / therapeutic use*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Warfarin
  • Thrombopoietin